# ASTON Sci.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aston-sci

- Industry: Biotechnology
- Headquarters: Hanam, South Korea
- Website: www.astonsci.com
- Total disclosed funding: $69M
- Latest round: Series D (Aug 20, 2026)
- Investors on record: 18

## About

Founded in 2018, and based in Seoul, South Korea, ASTON Sci. Inc. operates as a biopharmaceutical company that develops oncology, immunology, and geriatrics-related medicines. The company was founded by its Chief Executive Officer Hun Jung, Chief Executive Officer and Chief Business Officer Harry Hunwoo Shin, Jihyun Kim, Cwangkwang Chung, and Ilboo Kim. In August 2026, ASTON Sci. Inc. raised KRW 39.6 billion in series D from returning investors SBI Investment, ID Ventures, Lakewood Partners and new investors Yuanta Investment, CKD Venture Capital, Solidus Investment, Korea Development Bank, Pathway Partners, Korea Investment Partners, DAYLI Partners, Kolon Investment and other unspecified investors. 


ASTON Sci conducts research, performs clinical development, and creates therapeutic medicine and vaccines for treating cancer. The company has ten clinical and preclinical pathways as of 2022, including two cancer therapeutic vaccines known as AST-301 and AST-021p. The Ministry of Food and Drug Safety is reviewing AST-301 for clinical trials, while AST-021p is in phase 1 clinical trial for advanced solid tumors.

By 2030, the company plans to extend its pipeline to 15 medications across four therapeutic domains, focusing on the efficient development of novel drugs with high unmet medical needs and clinical demand. By early 2023, the company also intends to list on the KOSDAQ in order to assist its clinical and business development.

## Funding rounds

- Series D, Aug 20, 2026, $28M — Korea Development Bank, CKD Venture Capital, Korea Investment Partners, Yuanta Investment, SBI Investment, Solidus Investment, ID Ventures, Kolon Investment, DAYLI Partners, Lakewood Partners, Pathway Partners
- Series C, Dec 23, 2021, $23M — G.N.TECH Venture Capital, Mirae Asset Venture Investment, NAU IB Capital, Time Folio Asset Management, Mirae Equity Partners, Giltedge Partners, Lakewood Partners, JC Asset Management
- Series B, Aug 14, 2020, $11M — G.N.TECH Venture Capital, Mirae Asset Venture Investment, Time Folio Asset Management
- Series A, Jun 29, 2019, $6.9M — G.N.TECH Venture Capital

## Investors

- G.N.TECH Venture Capital (https://capitalatlas.ai/funds/g-n-tech-venture-capital) — Series A, Series B, Series C
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series B, Series C
- Time Folio Asset Management — Series B, Series C
- NAU IB Capital (https://capitalatlas.ai/funds/nau-ib-capital) — Series C
- Mirae Equity Partners (https://capitalatlas.ai/funds/mirae-equity-partners) — Series C
- Giltedge Partners — Series C
- Lakewood Partners (https://capitalatlas.ai/funds/lakewood-partners) — Series C, Series D
- JC Asset Management — Series C
- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series D
- CKD Venture Capital (https://capitalatlas.ai/funds/ckd-venture-capital) — Series D
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series D
- Yuanta Investment (https://capitalatlas.ai/funds/yuanta-investment) — Series D
- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series D
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series D
- ID Ventures (https://capitalatlas.ai/funds/id-ventures) — Series D
- Kolon Investment (https://capitalatlas.ai/funds/kolon-investment) — Series D
- DAYLI Partners (https://capitalatlas.ai/funds/dayli-partners) — Series D
- Pathway Partners (https://capitalatlas.ai/funds/pathway-partners) — Series D